Success Metrics

Clinical Success Rate
77.7%

Based on 227 completed trials

Completion Rate
78%(227/292)
Active Trials
150(24%)
Results Posted
40%(91 trials)
Terminated
65(11%)

Phase Distribution

Ph not_applicable
139
23%
Ph phase_4
11
2%
Ph phase_2
199
32%
Ph phase_1
36
6%
Ph phase_3
65
11%
Ph early_phase_1
5
1%

Phase Distribution

41

Early Stage

199

Mid Stage

76

Late Stage

Phase Distribution455 total trials
Early Phase 1First-in-human
5(1.1%)
Phase 1Safety & dosage
36(7.9%)
Phase 2Efficacy & side effects
199(43.7%)
Phase 3Large-scale testing
65(14.3%)
Phase 4Post-market surveillance
11(2.4%)
N/ANon-phased studies
139(30.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.1%

227 of 315 finished

Non-Completion Rate

27.9%

88 ended early

Currently Active

150

trials recruiting

Total Trials

614

all time

Status Distribution
Active(188)
Completed(227)
Terminated(88)
Other(111)

Detailed Status

Completed227
unknown111
Recruiting101
Terminated65
Active, not recruiting49
Not yet recruiting35

Development Timeline

Analytics

Development Status

Total Trials
614
Active
150
Success Rate
77.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 15 (1.1%)
Phase 136 (7.9%)
Phase 2199 (43.7%)
Phase 365 (14.3%)
Phase 411 (2.4%)
N/A139 (30.5%)

Trials by Status

unknown11118%
completed22737%
terminated6511%
withdrawn234%
not_yet_recruiting356%
recruiting10116%
active_not_recruiting498%
enrolling_by_invitation30%

Recent Activity

Clinical Trials (614)

Showing 20 of 614 trialsScroll for more
NCT06561308Phase 2

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Recruiting
NCT06906887Phase 2

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

Recruiting
NCT01339052Phase 2

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Completed
NCT07729670Phase 2

Multimodal Ablation Combined With Perioperative Tislelizumab and Chemotherapy for Resectable II-IIIB NSCLC

Not Yet Recruiting
NCT06944470Phase 2

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

Active Not Recruiting
NCT06702033Phase 2

The Minimalist Trial-2

Recruiting
NCT07718802Not Applicable

Observational Approach Versus Surgical Intervention for Stones

Not Yet Recruiting
NCT06660810Phase 2

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

Active Not Recruiting
NCT06358469Not Applicable

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

Recruiting
NCT06476067

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

Recruiting
NCT02364557Phase 2

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

Completed
NCT06915909Not Applicable

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

Recruiting
NCT03879109Phase 3

Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer

Completed
NCT07667296Phase 3

APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma

Not Yet Recruiting
NCT05839990Not Applicable

Biomechanical Properties of the Human Ascending Aortic Wall in Aneurysm

Completed
NCT06914440Phase 2

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

Recruiting
NCT03896620

Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma

Active Not Recruiting
NCT07339488Phase 2

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

Recruiting
NCT07652489

Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study

Recruiting
NCT02792582Phase 2

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

Active Not Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
614